Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase 4 3Phase 3 3Phase 2 3Phase 1 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 2760Carcinoma, Non-Small-Cell Lung 2260Prostatic Neoplasms 1425Colorectal Neoplasms 1290Neoplasms 1258Multiple Myeloma 1084Lung Neoplasms 1048Neoplasm Metastasis 994Leukemia, Myeloid, Acute 984Lymphoma 900Melanoma 862Pancreatic Neoplasms 818Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 753Recurrence 750Leukemia 733Lymphoma, Non-Hodgkin 684Leukemia, Lymphocytic, Chronic, B-Cell 665Lymphoma, Large B-Cell, Diffuse 616Squamous Cell Carcinoma of Head and Neck 615Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 596Brain Neoplasms 592Carcinoma, Renal Cell 586Glioblastoma 572Rectal Neoplasms 563Myelodysplastic Syndromes 522Sarcoma 521Lymphoma, Follicular 516

Interventions

Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Neuroma × Clear all
NCT06915662 2026-04-17

Pain Outcomes After Digital Amputation Using Tulavi Allayâ„¢ Nerve Cap

Massachusetts General Hospital

Phase 2 Recruiting
20 enrolled

Neuralgia, Neuroma

NCT01374191 2015-08-26

Botulinum Toxin Type A for Neuroma Pain

Southern Illinois University

Phase 2 Withdrawn

Neuroma, Pain, Chronic Pain

NCT00130962 2005-10-03

ALGRX 4975 in the Treatment of Patients With Morton's Neuroma

AlgoRx Pharmaceuticals

Phase 2 Completed
60 enrolled

Morton Neuroma, Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡